Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans' Health Administration | Abt Associates

Skip to main content

This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans' Health Administration

Schaefer M, DeLattre M, Gao X, Stephens J, Botteman M, Morreale A

Article

January 1, 2005